NxStage Medical, Inc.
CIK 0001333170
Revenue (TTM)
—
Q3 Nov 2018
Net Income (TTM)
−$11.61M
+73.1% YoY
Q3 Nov 2018
EPS Diluted (TTM)
—
Q3 Nov 2018
Gross Margin
—
Q3 Nov 2018
Operating Margin
—
Q3 Nov 2018
Net Margin
—
Q3 Nov 2018
Free Cash Flow (TTM)
−$3.28M
Q3 Nov 2018
Cash
$81.94M
Q3 Nov 2018
Total Debt
$545K
Q3 Nov 2018
Shares Outstanding
66.68M sh
Q3 Nov 2018
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.